Table 2.
Details of respondents’ fellowship training.
| Feature | No. (%) |
|---|---|
| Fellowship training (n = 148) | |
| Yes | 115 (77.7) |
| No | 33 (22.3) |
| More than one fellowship (n = 103) | |
| Yes | 15 (14.6) |
| No | 88 (85.4) |
| Unknown | 12 (N/A) |
| Length (months) of fellowship (n = 115) | |
| ≤11 | 10 (8.7) |
| 12 | 77 (67.0) |
| 13–23 | 24 (20.9) |
| ≥24 | 4 (3.5) |
| Fellowship location (n = 115, multiple locations permitted) | |
| Ontario | 48 (38.7) |
| United States | 29 (23.4) |
| Europe | 14 (11.3) |
| British Columbia | 11 (8.9) |
| Alberta | 11 (8.9) |
| Australia | 4 (3.2) |
| Manitoba | 2 (1.6) |
| Quebec | 2 (1.6) |
| United Kingdom | 1 (0.9) |
| New Zealand | 1 (0.9) |
| Japan | 1 (0.9) |
| Fellowship focus (n = 115, multiple selections permitted) | |
| Modern radiotherapy delivery technology | 73 (63.5) |
| Specific cancer site | 47 (41.8) |
| Stereotactic radiotherapy | 38 (33.0) |
| Research | 26 (22.6) |
| Brachytherapy | 21 (18.3) |
| Palliative care | 5 (4.3) |
| Medical education | 3 (2.6) |
| Proton and/or charged particle radiotherapy | 2 (1.7) |
| Type of fellowship (n = 115; multiple selections permitted) | |
| Clinical only | 4 (3.5) |
| Mostly clinical, but some research | 64 (55.7) |
| Mostly research, but some clinical | 35 (30.4) |
| Research leading to Master’s or Ph.D. | 13 (11.3) |
n indicates numbers of respondents to each question
Radiotherapy delivery technology includes 3D conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, or volumetric modulated arc therapy
Stereotactic radiotherapy includes stereotactic radiosurgery or stereotactic body radiotherapy
Research includes clinical, imaging, population health, basic or translational research